nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—muscle cancer	0.726	1	CbGaD
Bismuth Subsalicylate—PTGS2—Etoposide—muscle cancer	0.0946	0.442	CbGbCtD
Bismuth Subsalicylate—PTGS1—Etoposide—muscle cancer	0.0799	0.373	CbGbCtD
Bismuth Subsalicylate—ALB—Methotrexate—muscle cancer	0.0394	0.184	CbGbCtD
Bismuth Subsalicylate—TF—embryo—muscle cancer	0.00262	0.116	CbGeAlD
Bismuth Subsalicylate—PTGS2—hindlimb—muscle cancer	0.00261	0.115	CbGeAlD
Bismuth Subsalicylate—PTGS2—appendage—muscle cancer	0.00224	0.0991	CbGeAlD
Bismuth Subsalicylate—TF—renal system—muscle cancer	0.00199	0.0879	CbGeAlD
Bismuth Subsalicylate—TF—bone marrow—muscle cancer	0.0015	0.0664	CbGeAlD
Bismuth Subsalicylate—TF—vagina—muscle cancer	0.00144	0.0636	CbGeAlD
Bismuth Subsalicylate—TF—head—muscle cancer	0.00133	0.0588	CbGeAlD
Bismuth Subsalicylate—TF—testis—muscle cancer	0.00128	0.0568	CbGeAlD
Bismuth Subsalicylate—Extravasation—Dactinomycin—muscle cancer	0.00113	0.0302	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Vincristine—muscle cancer	0.00101	0.027	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Dactinomycin—muscle cancer	0.000899	0.0241	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Dactinomycin—muscle cancer	0.000829	0.0222	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Etoposide—muscle cancer	0.000816	0.0219	CcSEcCtD
Bismuth Subsalicylate—PTGS2—embryo—muscle cancer	0.000744	0.0329	CbGeAlD
Bismuth Subsalicylate—Lethargy—Dactinomycin—muscle cancer	0.000729	0.0195	CcSEcCtD
Bismuth Subsalicylate—Deafness—Vincristine—muscle cancer	0.000713	0.0191	CcSEcCtD
Bismuth Subsalicylate—Venous thrombosis—Doxorubicin—muscle cancer	0.000684	0.0183	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Etoposide—muscle cancer	0.00068	0.0182	CcSEcCtD
Bismuth Subsalicylate—ALB—testis—muscle cancer	0.000668	0.0295	CbGeAlD
Bismuth Subsalicylate—Oesophagitis—Etoposide—muscle cancer	0.000651	0.0174	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Vincristine—muscle cancer	0.000641	0.0172	CcSEcCtD
Bismuth Subsalicylate—Gastric ulcer—Doxorubicin—muscle cancer	0.000635	0.017	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Methotrexate—muscle cancer	0.000614	0.0165	CcSEcCtD
Bismuth Subsalicylate—PTGS1—smooth muscle tissue—muscle cancer	0.000612	0.0271	CbGeAlD
Bismuth Subsalicylate—Lung disorder—Methotrexate—muscle cancer	0.000602	0.0162	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Etoposide—muscle cancer	0.0006	0.0161	CcSEcCtD
Bismuth Subsalicylate—PTGS1—renal system—muscle cancer	0.000589	0.026	CbGeAlD
Bismuth Subsalicylate—PTGS2—smooth muscle tissue—muscle cancer	0.000585	0.0259	CbGeAlD
Bismuth Subsalicylate—PTGS2—renal system—muscle cancer	0.000563	0.0249	CbGeAlD
Bismuth Subsalicylate—Burning sensation—Doxorubicin—muscle cancer	0.000531	0.0143	CcSEcCtD
Bismuth Subsalicylate—PTGS1—cardiac atrium—muscle cancer	0.000527	0.0233	CbGeAlD
Bismuth Subsalicylate—Lung disorder—Doxorubicin—muscle cancer	0.000522	0.014	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Dactinomycin—muscle cancer	0.000494	0.0132	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Methotrexate—muscle cancer	0.000489	0.0131	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Dactinomycin—muscle cancer	0.000467	0.0125	CcSEcCtD
Bismuth Subsalicylate—PTGS1—tendon—muscle cancer	0.00046	0.0203	CbGeAlD
Bismuth Subsalicylate—Stinging—Doxorubicin—muscle cancer	0.000456	0.0122	CcSEcCtD
Bismuth Subsalicylate—PTGS2—tendon—muscle cancer	0.000439	0.0194	CbGeAlD
Bismuth Subsalicylate—Hallucination—Vincristine—muscle cancer	0.000439	0.0118	CcSEcCtD
Bismuth Subsalicylate—Erythema—Dactinomycin—muscle cancer	0.00043	0.0115	CcSEcCtD
Bismuth Subsalicylate—PTGS1—vagina—muscle cancer	0.000427	0.0189	CbGeAlD
Bismuth Subsalicylate—PTGS2—bone marrow—muscle cancer	0.000426	0.0188	CbGeAlD
Bismuth Subsalicylate—Extravasation—Doxorubicin—muscle cancer	0.000423	0.0114	CcSEcCtD
Bismuth Subsalicylate—PTGS2—vagina—muscle cancer	0.000408	0.018	CbGeAlD
Bismuth Subsalicylate—Skin exfoliation—Methotrexate—muscle cancer	0.000407	0.0109	CcSEcCtD
Bismuth Subsalicylate—PTGS1—head—muscle cancer	0.000394	0.0174	CbGeAlD
Bismuth Subsalicylate—Ecchymosis—Methotrexate—muscle cancer	0.000386	0.0103	CcSEcCtD
Bismuth Subsalicylate—PTGS1—testis—muscle cancer	0.000381	0.0168	CbGeAlD
Bismuth Subsalicylate—PTGS2—head—muscle cancer	0.000377	0.0167	CbGeAlD
Bismuth Subsalicylate—Skin exfoliation—Doxorubicin—muscle cancer	0.000353	0.00946	CcSEcCtD
Bismuth Subsalicylate—Oedema—Dactinomycin—muscle cancer	0.000351	0.00941	CcSEcCtD
Bismuth Subsalicylate—Infection—Dactinomycin—muscle cancer	0.000349	0.00935	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Etoposide—muscle cancer	0.000338	0.00907	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Doxorubicin—muscle cancer	0.000337	0.00905	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Dactinomycin—muscle cancer	0.000335	0.00897	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Doxorubicin—muscle cancer	0.000334	0.00895	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Methotrexate—muscle cancer	0.000316	0.00847	CcSEcCtD
Bismuth Subsalicylate—Oedema—Vincristine—muscle cancer	0.000314	0.00841	CcSEcCtD
Bismuth Subsalicylate—Infection—Vincristine—muscle cancer	0.000312	0.00836	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Doxorubicin—muscle cancer	0.000311	0.00835	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Dactinomycin—muscle cancer	0.000305	0.00818	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Etoposide—muscle cancer	0.000305	0.00817	CcSEcCtD
Bismuth Subsalicylate—Pain—Dactinomycin—muscle cancer	0.0003	0.00805	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Vincristine—muscle cancer	0.000299	0.00802	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Dactinomycin—muscle cancer	0.000289	0.00776	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Dactinomycin—muscle cancer	0.000277	0.00744	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Doxorubicin—muscle cancer	0.000274	0.00734	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Vincristine—muscle cancer	0.000273	0.00731	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Doxorubicin—muscle cancer	0.000269	0.00722	CcSEcCtD
Bismuth Subsalicylate—Pain—Vincristine—muscle cancer	0.000268	0.00719	CcSEcCtD
Bismuth Subsalicylate—Constipation—Vincristine—muscle cancer	0.000268	0.00719	CcSEcCtD
Bismuth Subsalicylate—Asthma—Methotrexate—muscle cancer	0.000268	0.00718	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Methotrexate—muscle cancer	0.000256	0.00688	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Etoposide—muscle cancer	0.000256	0.00687	CcSEcCtD
Bismuth Subsalicylate—Infection—Etoposide—muscle cancer	0.000252	0.00677	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Vincristine—muscle cancer	0.000248	0.00665	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Doxorubicin—muscle cancer	0.000245	0.00657	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Etoposide—muscle cancer	0.000242	0.00649	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Dactinomycin—muscle cancer	0.00024	0.00644	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Methotrexate—muscle cancer	0.000239	0.0064	CcSEcCtD
Bismuth Subsalicylate—Asthma—Doxorubicin—muscle cancer	0.000232	0.00621	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Etoposide—muscle cancer	0.000226	0.00606	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Methotrexate—muscle cancer	0.000225	0.00604	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Dactinomycin—muscle cancer	0.000223	0.00599	CcSEcCtD
Bismuth Subsalicylate—Rash—Dactinomycin—muscle cancer	0.000221	0.00594	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Etoposide—muscle cancer	0.000221	0.00592	CcSEcCtD
Bismuth Subsalicylate—Pain—Etoposide—muscle cancer	0.000217	0.00583	CcSEcCtD
Bismuth Subsalicylate—Constipation—Etoposide—muscle cancer	0.000217	0.00583	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Vincristine—muscle cancer	0.000215	0.00575	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Methotrexate—muscle cancer	0.000214	0.00574	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Doxorubicin—muscle cancer	0.000211	0.00566	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Etoposide—muscle cancer	0.000209	0.00561	CcSEcCtD
Bismuth Subsalicylate—Nausea—Dactinomycin—muscle cancer	0.000208	0.00559	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Vincristine—muscle cancer	0.000207	0.00556	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Doxorubicin—muscle cancer	0.000207	0.00554	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Methotrexate—muscle cancer	0.000202	0.00543	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Etoposide—muscle cancer	0.000202	0.00541	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Etoposide—muscle cancer	0.000201	0.00539	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Methotrexate—muscle cancer	0.0002	0.00536	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Vincristine—muscle cancer	0.000199	0.00535	CcSEcCtD
Bismuth Subsalicylate—Rash—Vincristine—muscle cancer	0.000198	0.0053	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Vincristine—muscle cancer	0.000198	0.0053	CcSEcCtD
Bismuth Subsalicylate—Headache—Vincristine—muscle cancer	0.000196	0.00527	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Doxorubicin—muscle cancer	0.000195	0.00523	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methotrexate—muscle cancer	0.000186	0.005	CcSEcCtD
Bismuth Subsalicylate—Nausea—Vincristine—muscle cancer	0.000186	0.005	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Doxorubicin—muscle cancer	0.000185	0.00497	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Methotrexate—muscle cancer	0.000183	0.0049	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Etoposide—muscle cancer	0.00018	0.00482	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Doxorubicin—muscle cancer	0.000175	0.0047	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Etoposide—muscle cancer	0.000174	0.00466	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Doxorubicin—muscle cancer	0.000173	0.00464	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Etoposide—muscle cancer	0.000168	0.00451	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Etoposide—muscle cancer	0.000161	0.00433	CcSEcCtD
Bismuth Subsalicylate—Erythema—Doxorubicin—muscle cancer	0.000161	0.00433	CcSEcCtD
Bismuth Subsalicylate—Rash—Etoposide—muscle cancer	0.00016	0.0043	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Etoposide—muscle cancer	0.00016	0.00429	CcSEcCtD
Bismuth Subsalicylate—Headache—Etoposide—muscle cancer	0.000159	0.00427	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Doxorubicin—muscle cancer	0.000158	0.00424	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Methotrexate—muscle cancer	0.000153	0.00411	CcSEcCtD
Bismuth Subsalicylate—Infection—Methotrexate—muscle cancer	0.000151	0.00405	CcSEcCtD
Bismuth Subsalicylate—Nausea—Etoposide—muscle cancer	0.000151	0.00405	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Methotrexate—muscle cancer	0.000145	0.00389	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Methotrexate—muscle cancer	0.000135	0.00363	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methotrexate—muscle cancer	0.000134	0.00359	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Doxorubicin—muscle cancer	0.000133	0.00356	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Methotrexate—muscle cancer	0.000132	0.00355	CcSEcCtD
Bismuth Subsalicylate—Oedema—Doxorubicin—muscle cancer	0.000132	0.00353	CcSEcCtD
Bismuth Subsalicylate—Infection—Doxorubicin—muscle cancer	0.000131	0.00351	CcSEcCtD
Bismuth Subsalicylate—Pain—Methotrexate—muscle cancer	0.00013	0.00349	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Doxorubicin—muscle cancer	0.000126	0.00337	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methotrexate—muscle cancer	0.000125	0.00336	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methotrexate—muscle cancer	0.000121	0.00324	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Methotrexate—muscle cancer	0.00012	0.00323	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Doxorubicin—muscle cancer	0.000117	0.00314	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Doxorubicin—muscle cancer	0.000116	0.00311	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Doxorubicin—muscle cancer	0.000115	0.00307	CcSEcCtD
Bismuth Subsalicylate—Pain—Doxorubicin—muscle cancer	0.000113	0.00302	CcSEcCtD
Bismuth Subsalicylate—Constipation—Doxorubicin—muscle cancer	0.000113	0.00302	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Doxorubicin—muscle cancer	0.000109	0.00291	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methotrexate—muscle cancer	0.000108	0.00289	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Doxorubicin—muscle cancer	0.000105	0.00281	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Doxorubicin—muscle cancer	0.000104	0.00279	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methotrexate—muscle cancer	0.000104	0.00279	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methotrexate—muscle cancer	0.000101	0.0027	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methotrexate—muscle cancer	9.67e-05	0.00259	CcSEcCtD
Bismuth Subsalicylate—Rash—Methotrexate—muscle cancer	9.59e-05	0.00257	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methotrexate—muscle cancer	9.58e-05	0.00257	CcSEcCtD
Bismuth Subsalicylate—Headache—Methotrexate—muscle cancer	9.53e-05	0.00256	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Doxorubicin—muscle cancer	9.32e-05	0.0025	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methotrexate—muscle cancer	9.04e-05	0.00242	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Doxorubicin—muscle cancer	9.01e-05	0.00242	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Doxorubicin—muscle cancer	8.71e-05	0.00234	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Doxorubicin—muscle cancer	8.38e-05	0.00225	CcSEcCtD
Bismuth Subsalicylate—Rash—Doxorubicin—muscle cancer	8.31e-05	0.00223	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Doxorubicin—muscle cancer	8.3e-05	0.00223	CcSEcCtD
Bismuth Subsalicylate—Headache—Doxorubicin—muscle cancer	8.25e-05	0.00221	CcSEcCtD
Bismuth Subsalicylate—Nausea—Doxorubicin—muscle cancer	7.83e-05	0.0021	CcSEcCtD
